While the authors found no correlation between urinary VEGF and tumor grade or recurrence, the significant elevation in bladder cancer patients aligns with broader evidence linking VEGF to poor prognosis across various malignancies. The gene discussed is VEGFA; the disease is urinary bladder carcinoma.